newsfilter
← Latest News
ClinicalTrials.gov·

A Study of Single and Multiple SC Doses of ALXN1830 in Healthy Adult Participants - NCT05254613

Number Of Participants With Treatment-emergent Adverse Events, Area Under The Plasma Concentration Versus Time Curve (AUC) Of Single And Multiple SC Doses Of ALXN1830, Maximum Observed Plasma Concentration (Cmax) Of Single And Multiple SC Doses Of ALXN1830, (and 2 more...)